These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35224839)

  • 41. C-terminal truncated SPOP, a Janus-faced variant, causing a mixed type 1 and type 2 Nabais Sa-de Vries syndrome.
    Law CY; Lam CW
    Clin Chim Acta; 2022 Oct; 535():187-194. PubMed ID: 36063898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
    Kosmicki JA; Samocha KE; Howrigan DP; Sanders SJ; Slowikowski K; Lek M; Karczewski KJ; Cutler DJ; Devlin B; Roeder K; Buxbaum JD; Neale BM; MacArthur DG; Wall DP; Robinson EB; Daly MJ
    Nat Genet; 2017 Apr; 49(4):504-510. PubMed ID: 28191890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A de novo truncating variant in CSDE1 in an adult-onset neuropsychiatric phenotype without intellectual disability.
    Krenn M; Kepa S; Kasprian G; Riedhammer KM; Wagner M; Goedl-Fleischhacker U; Milenkovic I
    Eur J Med Genet; 2022 Mar; 65(3):104423. PubMed ID: 35026469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrent
    Tan NB; Pagnamenta AT; Ferla MP; Gadian J; Chung BH; Chan MC; Fung JL; Cook E; Guter S; Boschann F; Heinen A; Schallner J; Mignot C; Keren B; Whalen S; Sarret C; Mittag D; Demmer L; Stapleton R; Saida K; Matsumoto N; Miyake N; Sheffer R; Mor-Shaked H; Barnett CP; Byrne AB; Scott HS; Kraus A; Cappuccio G; Brunetti-Pierri N; Iorio R; Di Dato F; Pais LS; Yeung A; Tan TY; Taylor JC; Christodoulou J; White SM
    J Med Genet; 2022 May; 59(5):511-516. PubMed ID: 34183358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel de novo KDM5C variant in a female with global developmental delay and ataxia: a case report.
    Lippa NC; Barua S; Aggarwal V; Pereira E; Bain JM
    BMC Neurol; 2021 Sep; 21(1):358. PubMed ID: 34530748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletions and de novo mutations of SOX11 are associated with a neurodevelopmental disorder with features of Coffin-Siris syndrome.
    Hempel A; Pagnamenta AT; Blyth M; Mansour S; McConnell V; Kou I; Ikegawa S; Tsurusaki Y; Matsumoto N; Lo-Castro A; Plessis G; Albrecht B; Battaglia A; Taylor JC; Howard MF; Keays D; Sohal AS; ; Kühl SJ; Kini U; McNeill A
    J Med Genet; 2016 Mar; 53(3):152-62. PubMed ID: 26543203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain.
    Marbach F; Stoyanov G; Erger F; Stratakis CA; Settas N; London E; Rosenfeld JA; Torti E; Haldeman-Englert C; Sklirou E; Kessler E; Ceulemans S; Nelson SF; Martinez-Agosto JA; Palmer CGS; Signer RH; ; Andrews MV; Grange DK; Willaert R; Person R; Telegrafi A; Sievers A; Laugsch M; Theiß S; Cheng Y; Lichtarge O; Katsonis P; Stocco A; Schaaf CP
    Genet Med; 2021 Aug; 23(8):1465-1473. PubMed ID: 33833410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders.
    Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis of CDK8-associated disorder: two patients with novel CDK8 variants and in vitro and in vivo functional analyses of the variants.
    Uehara T; Abe K; Oginuma M; Ishitani S; Yoshihashi H; Okamoto N; Takenouchi T; Kosaki K; Ishitani T
    Sci Rep; 2020 Oct; 10(1):17575. PubMed ID: 33067521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. De novo CLCN3 variants affecting Gly327 cause severe neurodevelopmental syndrome with brain structural abnormalities.
    Nakashima M; Argilli E; Nakano S; Sherr EH; Kato M; Saitsu H
    J Hum Genet; 2023 Apr; 68(4):291-298. PubMed ID: 36536096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expanding the clinical phenotype of the ultra-rare Skraban-Deardorff syndrome: Two novel individuals with WDR26 loss-of-function variants and a literature review.
    Pavinato L; Trajkova S; Grosso E; Giorgio E; Bruselles A; Radio FC; Pippucci T; Dimartino P; Tartaglia M; Petlichkovski A; De Rubeis S; Buxbaum J; Ferrero GB; Keller R; Brusco A
    Am J Med Genet A; 2021 Jun; 185(6):1712-1720. PubMed ID: 33675273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.
    Fountain MD; Oleson DS; Rech ME; Segebrecht L; Hunter JV; McCarthy JM; Lupo PJ; Holtgrewe M; Moran R; Rosenfeld JA; Isidor B; Le Caignec C; Saenz MS; Pedersen RC; Morgan TM; Pfotenhauer JP; Xia F; Bi W; Kang SL; Patel A; Krantz ID; Raible SE; Smith W; Cristian I; Torti E; Juusola J; Millan F; Wentzensen IM; Person RE; Küry S; Bézieau S; Uguen K; Férec C; Munnich A; van Haelst M; Lichtenbelt KD; van Gassen K; Hagelstrom T; Chawla A; Perry DL; Taft RJ; Jones M; Masser-Frye D; Dyment D; Venkateswaran S; Li C; Escobar LF; Horn D; Spillmann RC; Peña L; Wierzba J; Strom TM; Parenti I; Kaiser FJ; Ehmke N; Schaaf CP
    Genet Med; 2019 Aug; 21(8):1797-1807. PubMed ID: 30679821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel splice site CUL3 variant in a patient with neurodevelopmental delay.
    Vincent KM; Bourque DK
    Brain Dev; 2023 Apr; 45(4):244-249. PubMed ID: 36710200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature.
    Murch O; Jain V; Benneche A; Metcalfe K; Hobson E; Prescott K; Chandler K; Ghali N; Carmichael J; Foulds NC; Paulsen J; Smeland MF; Berland S; Fry AE
    Eur J Hum Genet; 2022 Jan; 30(1):95-100. PubMed ID: 34645992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterozygous loss-of-function DHX9 variants are associated with neurodevelopmental disorders: Human genetic and experimental evidences.
    Yamada M; Nitta Y; Uehara T; Suzuki H; Miya F; Takenouchi T; Tamura M; Ayabe S; Yoshiki A; Maeno A; Saga Y; Furuse T; Yamada I; Okamoto N; Kosaki K; Sugie A
    Eur J Med Genet; 2023 Aug; 66(8):104804. PubMed ID: 37369308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genotype-phenotype correlation at codon 1740 of SETD2.
    Rabin R; Radmanesh A; Glass IA; Dobyns WB; Aldinger KA; Shieh JT; Romoser S; Bombei H; Dowsett L; Trapane P; Bernat JA; Baker J; Mendelsohn NJ; Popp B; Siekmeyer M; Sorge I; Sansbury FH; Watts P; Foulds NC; Burton J; Hoganson G; Hurst JA; Menzies L; Osio D; Kerecuk L; Cobben JM; Jizi K; Jacquemont S; Bélanger SA; Löhner K; Veenstra-Knol HE; Lemmink HH; Keller-Ramey J; Wentzensen IM; Punj S; McWalter K; Lenberg J; Ellsworth KA; Radtke K; Akbarian S; Pappas J
    Am J Med Genet A; 2020 Sep; 182(9):2037-2048. PubMed ID: 32710489
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Hubert L; Cannata Serio M; Villoing-Gaudé L; Boddaert N; Kaminska A; Rio M; Lyonnet S; Munnich A; Poirier K; Simons M; Besmond C
    J Med Genet; 2020 Feb; 57(2):138-144. PubMed ID: 31439720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.